INNOVENTRIC

💡 Simple may be best for #TTVR in patients with severe #TR. Trillium is a streamlined solution with a shorter implantation time and no echo guidance or general anesthesia needed. 🏥 #NYValves2024 📊 👉 tctmd.com/slide/heteroto… @PhilippLurz #InnovationWithPurpose @gu_asc1

If you missed the presentation and would like to view it and get updated with our progress, here is the link: lifesciencemarketresearch.com/videos/amir-da…

Thank you, #LSIUSA24, for the incredible opportunity to present our #Trillium technology, a heterotopic cross-caval tricuspid regurgitation treatment, at the esteemed #MedTech event in Dana Point, California. #InterventionalCardiology

Join Amir Danino, the founder and CEO of @innoventric at #LSIUSA24 on March 19th, 09:05 AM. Amir will present our heterotopic tricuspid valve replacement technology, a unique and novel solution for all tricuspid regurgitation patients. #InterventionalCardiology